Clinical Trial Update: Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1

View source ↗

Summary

A Stanford University–led clinical trial evaluating genetic modifiers of cutaneous neurofibromas in adults with Neurofibromatosis type 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: Stanford University | Conditions: Neurofibromatosis 1 | Status: COMPLETED